CorMedix (CRMD) PT Lowered to $16 at Truist Securities
Tweet
Share
E-mailGet Alerts CRMD Hot Sheet
Price: $8.14 +14.65%
Rating Summary:
10 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Rating Summary:
10 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Join SI Premium – FREE
Truist Securities analyst Joon Lee lowered the price target on CorMedix (NASDAQ: CRMD) to $16.00 (from $27.00) while maintaining a Buy rating.
You May Also Be Interested In
- CorMedix (CRMD) Tops Q2 EPS by 6c; Offers Guidance
- Resideo Technologies (REZI) PT Lowered to $27 at Oppenheimer
- Yeti Holdings Inc. (YETI) PT Raised to $56 at Raymond James
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
